Compare BKKT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKKT | STXS |
|---|---|---|
| Founded | 2018 | 1990 |
| Country | United States | United States |
| Employees | 48 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.4M | 177.0M |
| IPO Year | N/A | 2004 |
| Metric | BKKT | STXS |
|---|---|---|
| Price | $8.19 | $1.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $21.50 | $4.00 |
| AVG Volume (30 Days) | ★ 1.2M | 334.2K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | N/A | $28.22 |
| Revenue Next Year | $261.39 | $30.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.87 | $1.67 |
| 52 Week High | $49.79 | $3.59 |
| Indicator | BKKT | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 44.33 |
| Support Level | $8.03 | $1.74 |
| Resistance Level | $10.51 | $1.95 |
| Average True Range (ATR) | 0.58 | 0.09 |
| MACD | 0.16 | 0.02 |
| Stochastic Oscillator | 59.28 | 35.85 |
Bakkt Inc builds digital financial infrastructure designed to support institutional participation in the digital asset economy. The company platform is built to accommodate various digital assets and offers its clients the flexibility to build a product that aligns with its vision and customers' needs. Its services include Bakkt Markets, Bakkt Agent, Bakkt Global.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.